Leaflet BERIGLOBIN P 160mg / ml solution for intramuscular injection


Indicated for: immunosuppression

Route of administration: intramuscular

Substance: normal human immunoglobulin for extravascular administration (immunoglobulin)

ATC: J06BA01 (Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human)

Normal human immunoglobulin for extravascular administration is used for the treatment and prevention of infections in patients with primary or secondary immune deficiencies. It contains antibodies that help strengthen the immune system.

The medication is administered subcutaneously, as directed by a doctor. The dose and frequency of administration are adjusted based on the patient's condition.

Side effects may include redness, swelling, or pain at the injection site, as well as general symptoms such as fever or fatigue. In rare cases, severe allergic reactions may occur.

Normal human immunoglobulin for extravascular administration is not recommended for patients with hypersensitivity to human immunoglobulins or severe IgA deficiency.

General data about BERIGLOBIN P 160mg / ml

  • Substance: normal human immunoglobulin for extravascular administration
  • Date of last drug list: 01-07-2013
  • Commercial code: W13304001
  • Concentration: 160mg / ml
  • Pharmaceutical form: solution for intramuscular injection
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.